Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).

My current assignment

Logic: Language & Information is a free Coursera course from the University of Melbourne. Presented by Jen Davoren and Greg Restall, the class starts on the 10th March 2014. http://coursera.org/course/logic1

https://vimeo.com/87822315


Logic: Language & Information from Video and Media Production on Vimeo.

Twitter handle: @logic1mooc
Why did I choose this course? I'm a Watson fan. Watson (IBM), Logic and Genomics, the perfect match!
https://class.coursera.org/logic1-001

https://class.coursera.org/logic1-001

Publié par le
Libellés :

Aucun commentaire:

Enregistrer un commentaire

Inscription à : Publier les commentaires (Atom)